Biotech · Private company
Mati Therapeutics Inc.
Track this companyFree. Adds Mati Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Nepafenac PPDSPhase 2 · PainClinicalTrials.gov · fetched Nov 12, 2026
- NDE L68 StableFit® Punctal PlugDry Eye SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- Travoprost Evolute® (Travoprost Punctal Plug Delivery System), 166 ugElevated Intraocular Pressure (IOP)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Safety and Intraocular Lowering Effect of Delivery of Travoprost Evolute® in Subjects With Elevated Intraocular PressureCOMPLETED · started Sep 8, 2021ClinicalTrials.gov NCT04962009 · fetched Nov 12, 2026
- An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear LakeNA · COMPLETED · started Aug 28, 2019ClinicalTrials.gov NCT04280653 · fetched Nov 12, 2026
- Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After CataractPHASE2 · COMPLETED · started Mar 5, 2018ClinicalTrials.gov NCT03496467 · fetched Nov 12, 2026